Company Avricore Health Inc Toronto S.E.
Equities
APH
CA92143R2046
Pharmaceuticals
Business Summary
Sales per Business
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Health Data and Point-of-care Technologies
100.0
%
| 0 | 100.0 % | 2 | 100.0 % | +1,339.95% |
Sales per region
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 0 | 100.0 % | 2 | 100.0 % | +1,339.95% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hector Bremner
CEO | Chief Executive Officer | - | 01/19/01 |
Kiki Smith
DFI | Director of Finance/CFO | - | 06/19/06 |
Rodger Seccombe
CTO | Chief Tech/Sci/R&D Officer | - | 08/20/08 |
Mark Kunzli
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Hall
CHM | Chairman | 71 | 20/16/20 |
Robert Sindelar
BRD | Director/Board Member | 71 | 27/18/27 |
Christine Hrudka
BRD | Director/Board Member | - | 21/23/21 |
Rodger Seccombe
CTO | Chief Tech/Sci/R&D Officer | - | 08/20/08 |
Alan Arnstein
BRD | Director/Board Member | 56 | 20/17/20 |
Hector Bremner
CEO | Chief Executive Officer | - | 01/19/01 |
Thomas Teahen
BRD | Director/Board Member | - | 21/23/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 99,869,664 | 90,194,935 ( 90.31 %) | 0 | 90.31 % |
Company contact information
Avricore Health, Inc.
789 West Pender Street Suite 1120
V6C 1H2, Vancouver
+
http://www.avricorehealth.comSector
1st Jan change | Capi. | |
---|---|---|
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |